Management of Hypoglycemia in Emergency LSCS After Betamethasone Administration
Immediate Hypoglycemia Management
- Administer IV glucose immediately to correct hypoglycemia in patients with blood sugar levels meeting the threshold for glucose administration in the perioperative setting, particularly if the patient cannot take oral glucose due to an emergency surgical situation, as recommended by the American Society of Anesthesiologists 1, 2
- IV glucose is mandatory for any patient who is unconscious, unable to swallow, or NPO for surgery, even if hypoglycemia symptoms are absent, according to the American College of Surgeons 2
- The guideline threshold is clear: glucose should be administered for blood sugar levels between 0.7 and 1 g/L (3.8-5.5 mmol/L) if the patient reports signs of hypoglycemia, or immediately if <3.3 mmol/L (0.6 g/L) regardless of symptoms, as stated by the American Diabetes Association 1, 2
Intraoperative Management
- Initiate continuous IV insulin infusion once hypoglycemia is corrected and maintain throughout the emergency LSCS procedure, with a target blood glucose range of 100-180 mg/dL (5.6-10.0 mmol/L) during the perioperative period, as recommended by the Society of Critical Care Medicine 3
- Monitor blood glucose hourly during surgery to maintain glycemic targets and reduce surgical complications, according to the American College of Surgeons 3
- Starting insulin infusion rate typically 0.5-1 unit/hour, adjusted to maintain glucose 140-180 mg/dL, as stated by the Endocrine Society 4
Postoperative Management
- Continue IV insulin infusion until blood glucose is stable ≤180 mg/dL (10 mmol/L) and the patient resumes oral feeding, as recommended by the American College of Physicians 1, 4
- Do not abruptly discontinue IV insulin as this leads to rebound hyperglycemia and potential ketoacidosis, especially critical given the betamethasone on board, according to the American Diabetes Association 4
Transition to Subcutaneous Insulin
- Calculate subcutaneous insulin doses based on total 24-hour IV insulin requirements when transitioning off IV therapy, with half of the total 24-hour IV insulin dose becoming the basal (long-acting) insulin given once in the evening, as recommended by the Endocrine Society 1, 4
- Give first subcutaneous basal insulin 1-2 hours before stopping IV infusion to ensure adequate overlap and prevent rebound hyperglycemia, according to the American Association of Clinical Endocrinologists 4
Critical Monitoring Requirements
- Check blood glucose every 1-2 hours while NPO and during IV insulin infusion, and monitor serum potassium closely to avoid hypokalemia during insulin therapy, as recommended by the Society of Critical Care Medicine 3, 4
- Scale up regular blood glucose monitoring given the dual risk of hypoglycemia from surgery/NPO status and hyperglycemia from betamethasone, according to the American Diabetes Association 1, 2
Key Pitfalls to Avoid
- Never delay surgery to "optimize" the blood sugar—correct the hypoglycemia with IV glucose and proceed with the emergency LSCS, as recommended by the American College of Surgeons 2
- Watch for hyperosmolarity in the postoperative period given the betamethasone-induced hyperglycemia, which presents with dehydration and confusion, according to the American College of Emergency Physicians 4
- Ensure adequate hydration alongside insulin therapy, as betamethasone-induced hyperglycemia may cause osmotic diuresis, as stated by the National Institute of Diabetes and Digestive and Kidney Diseases 4